Spyre Therapeutics, Inc. (SYRE)
40.16
-0.43
(-1.06%)
USD |
NASDAQ |
Mar 06, 16:00
40.16
0.00 (0.00%)
After-Hours: 17:41
Spyre Therapeutics Research and Development Expense (TTM) : 171.65M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 102.38M |
| PTC Therapeutics, Inc. | 455.25M |
| Agios Pharmaceuticals, Inc. | 334.36M |
| Tandem Diabetes Care, Inc. | 192.28M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |